Authors
Petar Mitev, Aditi Khurana, Caroline Eriksson, Elisa Saccon, Saeed Eshtad, Sofie Vonlanthen, Bianca Tesi, Elham Dadfar, AnnaCarin Horne, Elisabeth Mellström, Martin Paucar, Mikael Sundin, Yenan T Bryceson
Published in
Journal of human immunity. Volume 3. Issue 1. Jan 04, 2027. Epub Nov 10, 2026.
Abstract
Germline gain-of-function (GoF) variants in the paralogous sterile alpha motif domain containing 9 (SAMD9) and SAMD9-like (SAMD9L) genes cause myelodysplasia, primary immunodeficiencies, and neurological disorders. Predicting the functional consequences of individual variants, however, remains challenging, owing partly to the complexity of these large, multidomain proteins. Here, we functionally characterized several rare patient-derived SAMD9/9L variants, identifying multiple novel GoF and loss-of-function (LoF) variants, including SAMD9L p.C883X-the shortest documented SAMD9L GoF truncation within the NTPase domain. SAMD9L NTPase domain truncations are associated with severe, early-onset pathology, yet despite the high structural and sequence similarity between the two proteins, analogous truncating variants have not been reported in SAMD9 patients. To examine whether this reflects a fundamental difference, we generated multiple homologous SAMD9 truncations, which, unlike their SAMD9L counterparts, exhibited LoF rather than GoF activity. Additionally, established computational pathogenicity predictors failed to identify pathogenic variants or distinguish GoF from LoF. Collectively, these results demonstrate that functional outcomes in SAMD9/9L cannot be reliably inferred from sequence, structure, or computational prediction alone, underscoring the importance of empirical characterization.
PMID:
43007090
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0